Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Daiichi reports novel cytokine production inhibitors in patent literature

Aug. 4, 1999

Novel selectin inhibitors revealed in the patent literature by Sumitomo

Aug. 2, 1999

Amgen discloses new class of cytokine production inhibitors

July 30, 1999

Aryl ureas for cytokine- and MMP-mediated conditions disclosed by Bayer

July 30, 1999

Cytokine production inhibitors from SB particularly useful for inflammation, osteoporosis

July 27, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

Fungal metabolites useful as IL-1/TNF production inhibitors

July 23, 1999

P2X7 receptor antagonists for inflammatory, immune and cardiovascular disorders

July 23, 1999

Licensing opportunity from NIH: broad-spectrum chemokine antagonist

July 22, 1999

Amgen reveals latest in inhibitors of matrix metalloproteinases

July 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...